2012 annual financial data
ADMA Biologics 2012 Operating margin
Direct answer
Operating margin was -707.36%.
Operating income was -7,909,169 USD and net income was -7,301,313 USD.
Operating cash flow was -6,903,795 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,118,118 USD
- Operating income
- -7,909,169 USD
- Net income
- -7,301,313 USD
- Operating cash flow
- -6,903,795 USD